Abstract
Atherosclerotic renovascular disease (ARVD) is a relatively common condition which may lead to progressive renal dysfunction, and eventually to end-stage renal failure. Revascularization has been used in an attempt to prevent progression of ARVD, despite a lack of evidence for a benefit on kidney function. Therefore, large-scale randomized trials are needed to determine reliably whether or not there is any worthwhile benefit. The Angioplasty and STent for Renal Artery Lesions (ASTRAL) trial comparing renal function in ARVD patients randomized to either revascularization or medical management alone was designed to provide this evidence. ASTRAL started recruiting in November 2000 and, as of the end of 2006, 731 patients have been randomized into the trial (19 patients short of its minimum target of 750 patients). A pooled analysis (not split by treatment arm) of all patients shows that serum creatinine increased in the first 6 months then remained relatively steady, whereas blood pressure has decreased from baseline. The trial is due to close to recruitment in April 2007, with the first presentation of the results of the randomized treatment comparison planned for the spring of 2008. To date ASTRAL is by far the largest randomized trial in ARVD, and will provide the most reliable and timely evidence on the role, if any, of revascularization in ARVD with which to guide the treatment of future patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Beskens E et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282–286.
Cheung CM, Hegarty J, Kalra PA . Dilemmas in the management of renal artery stenosis. Br Med Bull 2005; 73–74: 35–55.
Ives NJ, Wheatley K, Stowe RL, Krijnen P, Pluoin PF, van Jaarsveld BC et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003; 18: 298–304.
Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG et al. Randomised comparison of percutaneous angioplasty vs continuous medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329–335.
Plouin PF, Chatellier G, Darne B, Raynaud A . Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angoiplastie (EMMA) Study Group. Hypertension 1998; 31: 823–829.
van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342: 1007–1014.
Wright JR, Shurrab Al E, Cooper A, Kalra PR, Foley RN, Kalra PA . Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 2005; 16: 2746–2753.
Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) Study: Rationale and Methods. J Vasc Interv Radiol 2005; 16: 1295–1300.
Acknowledgements
We thank all the collaborators who have entered patients into the ASTRAL trial and the patients who have agreed to take part in the trial.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Mistry, S., Ives, N., Harding, J. et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens 21, 511–515 (2007). https://doi.org/10.1038/sj.jhh.1002185
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002185
Keywords
This article is cited by
-
Die Nierenarterienstenose
Medizinische Klinik (2009)
-
Pleiotropic Effects of Statins May Improve Outcomes in Atherosclerotic Renovascular Disease
American Journal of Hypertension (2008)
-
Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans
Nature Clinical Practice Nephrology (2008)
-
Abdominal MR Angiography with blood pool agents
European Radiology Supplements (2008)
-
Angioplasty for atheromatous renal artery stenosis: current knowledge and trial results awaited
Journal of Human Hypertension (2007)